Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alterations in PACAP, CGRP, and VIP Levels in Rosacea Patients Receiving Systemic Isotretinoin Treatment: Association with Erythema Index

NCT06873087 is registered in ClinicalTrials.gov with SB Istanbul Education and Research Hospital as lead sponsor.

NCT NCT06873087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06873087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alterations in PACAP, CGRP, and VIP Levels in Rosacea Patients Receiving Systemic Isotretinoin Treatment: Association with Erythema Index
Lead sponsor
SB Istanbul Education and Research Hospital
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2023
Completion date
June 30, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rosacea